Dyspepsia Flashcards
What do goblet cells secrete?
Mucus (protects stomach lining)
What do parietal cells secrete?
Gastric acid (e.g. HCl)
What do chief cells secrete?
Pepsinogen (protease precursor)
What do D cells secrete?
Somatostatin (inhibits acid secretion)
What do G cells secrete?
Gastrin (stimulates acid secretion)
What has positive effect on parietal cells?
Histamine, gastrin and ACh –> increases gastric acid production
What is ACh released by?
Enteric neuron
What is effect of somatostatin?
Inhibitory on gastric acid secretion (parietal cells), histamine and gastrin (G cells)
How do proton pump inhibitors and H2 blockers reduce gastric acid secretion?
Inhibit pathways
What are the different dyspepsia terms?
- Dyspepsia with alarm symptoms: Dyspepsia with “red-flag” features
- Uncomplicated (or simple) dyspepsia: Dyspepsia without “red-flag” features
- Uninvestigated dyspepsia: Dyspepsia presenting to a physician for the first time
- Functional (“non-ulcer”) dyspepsia: Dyspepsia, but no structural cause for symptoms at upper GI endoscopy
What are the alarm features of dyspepsia?
Weight loss Dysphagia or odynophagia Persistent vomiting Haematemesis or melaena Palpable epigastric mass Family history of gastric cancer Dyspepsia onset over age of 45-55 years
What are the potential causes of dyspepsia?
- Gastro-oesophageal reflux disease
- Peptic ulcer
- Gastric cancer
But ~80% of people with dyspepsia will have a normal endoscopy –> This is so-called functional dyspepsia
How is dyspepsia with alarm symptoms managed?
Urgent endoscopy (but accuracy poor in predicting upper GI cancer)
What are individuals with dyspepsia tested for?
H. pylori (eradication therapy for positives)
How do we decide which approach to use for dyspepsia?
- Prompt endoscopy:
Is best in terms of effect on symptoms
But, costs much more per patient
Not cost-effective - “Test & treat” for H. pylori or empirical PPI therefore preferable:
Effect on both symptoms and costs very similar
Which to use depends on population prevalence of H. pylori
If prevalence >10%, “test and treat” preferred